WESTBURY, N.Y., June 28, 2021 /PRNewswire/ — BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the acquisition of Valley Biomedical ...
“We aim to be the driver of precision medicine in Taiwan and the rest of the world,” assures Louis Cheng, CEO of Leadgene Biomedical. To achieve this goal, Leadgene draws on both its long experience ...
Chromatrap® announces that BioLegend, a major US-based manufacturer and supplier of reagents and kits for biomedical research, has chosen their novel solid-state ChIP technology to power a new range ...
Leadgene Biomedical, Inc., an ISO-certificated contract development and manufacturing organization (CDMO) company that provides integrated service for in-vitro diagnostics (IVD) products from the ...
NEW YORK--(BUSINESS WIRE)--BioLegend, Inc. (“BioLegend”) and the New York Genome Center (“NYGC”) announced today that they have entered into an exclusive worldwide license and collaborative research ...
Just like the wrong ingredients can spoil a cake, so too can the wrong ingredients spoil the results in biomedical research. The difference is that the latter involves years of work, financial and ...
HONG KONG, Oct. 30, 2019 /PRNewswire/ -- Huakang Biomedical Holdings Company Limited ("Huakang Biomedical", the "Group", HKSE：08622) is pleased to announce that Huakang Biomedical Company Limited ...
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback